Novolog (Pharm-Up 1966) Ltd (TLV: NVLG)
Israel
· Delayed Price · Currency is ILS · Price in ILA
169.50
+7.00 (4.31%)
Nov 19, 2024, 5:24 PM IDT
Novolog (Pharm-Up 1966) Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -17.54 | -42 | 47.51 | 42.32 | 40.07 | 10.14 | Upgrade
|
Depreciation & Amortization | 96.25 | 93.81 | 36.68 | 38.48 | 37.76 | 37.4 | Upgrade
|
Other Amortization | 10.17 | 10.17 | 7.86 | - | - | - | Upgrade
|
Loss (Gain) From Sale of Assets | 0.11 | 0.14 | -0.34 | -0.53 | -3.56 | -0.38 | Upgrade
|
Loss (Gain) on Equity Investments | 4.65 | 30.64 | 4.61 | 1.64 | - | - | Upgrade
|
Stock-Based Compensation | 3.17 | -0.16 | 2.35 | 2.58 | 3.27 | 2.02 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | - | - | 0.05 | - | Upgrade
|
Other Operating Activities | 4.69 | 0.67 | 15.84 | 15.47 | 10.53 | 25.99 | Upgrade
|
Change in Accounts Receivable | -92.78 | -242.32 | -7.35 | -14.65 | -8.63 | -18.14 | Upgrade
|
Change in Inventory | 9.2 | -57.43 | -2.16 | 69.51 | -41.1 | -33.36 | Upgrade
|
Change in Accounts Payable | 20.08 | 418.31 | 41.17 | -60.47 | 2.21 | 89.69 | Upgrade
|
Change in Income Taxes | 3.98 | -5.63 | -11.08 | -3.85 | 0.73 | 2.79 | Upgrade
|
Change in Other Net Operating Assets | 6.58 | -6.19 | -2.45 | -7.11 | 17.14 | -14.69 | Upgrade
|
Operating Cash Flow | 48.58 | 200.01 | 132.65 | 83.39 | 58.49 | 101.45 | Upgrade
|
Operating Cash Flow Growth | -83.54% | 50.78% | 59.08% | 42.58% | -42.35% | 323.38% | Upgrade
|
Capital Expenditures | -60.86 | -70.96 | -69.49 | -30.64 | -25.61 | -25.01 | Upgrade
|
Sale of Property, Plant & Equipment | 0.34 | 0.18 | 0.97 | 2.52 | 1.8 | 0.62 | Upgrade
|
Cash Acquisitions | - | -9.71 | -50.9 | -19.02 | -7.17 | -36.55 | Upgrade
|
Investment in Securities | -0.16 | -3.1 | -11.93 | -26.71 | - | - | Upgrade
|
Other Investing Activities | 11.63 | 10.98 | 6.41 | 4.78 | 2.37 | 1.47 | Upgrade
|
Investing Cash Flow | -51.3 | -72.6 | -124.95 | -69.07 | -28.61 | -59.47 | Upgrade
|
Short-Term Debt Repaid | - | -0.07 | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -23.54 | -18.79 | -28.97 | -21.11 | -54.96 | Upgrade
|
Total Debt Repaid | -27.25 | -23.61 | -18.79 | -28.97 | -21.11 | -54.96 | Upgrade
|
Net Debt Issued (Repaid) | -27.25 | -23.61 | -18.79 | -28.97 | -21.11 | -54.96 | Upgrade
|
Issuance of Common Stock | - | - | - | 119.83 | 0.03 | 120.61 | Upgrade
|
Common Dividends Paid | -15 | -16.9 | -31.9 | -32 | -12 | -15.5 | Upgrade
|
Other Financing Activities | -41.78 | -27.2 | -22.27 | -11.37 | -6.77 | -14.39 | Upgrade
|
Financing Cash Flow | -84.03 | -67.71 | -72.96 | 47.49 | -39.85 | 35.76 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.69 | 0.44 | -0.64 | 0.46 | 1.3 | -0.61 | Upgrade
|
Net Cash Flow | -86.07 | 60.13 | -65.9 | 62.27 | -8.67 | 77.14 | Upgrade
|
Free Cash Flow | -12.28 | 129.06 | 63.16 | 52.75 | 32.87 | 76.44 | Upgrade
|
Free Cash Flow Growth | - | 104.34% | 19.73% | 60.48% | -57.00% | - | Upgrade
|
Free Cash Flow Margin | -0.73% | 7.85% | 4.19% | 4.20% | 2.90% | 7.61% | Upgrade
|
Free Cash Flow Per Share | -0.02 | 0.25 | 0.12 | 0.10 | 0.07 | 0.20 | Upgrade
|
Cash Interest Paid | 11.22 | 11.25 | 11.44 | 7.62 | 6.77 | 14.39 | Upgrade
|
Cash Income Tax Paid | 13.78 | 22.07 | 33.8 | 19 | 12.39 | 4.02 | Upgrade
|
Levered Free Cash Flow | 10.15 | 156.96 | 38.37 | 27.94 | 25.78 | 69.15 | Upgrade
|
Unlevered Free Cash Flow | 20.47 | 165 | 46.2 | 33.23 | 30.39 | 73.98 | Upgrade
|
Change in Net Working Capital | 62.49 | -98.4 | -20.16 | 20.57 | 20.98 | -34.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.